| 39.06 -0.04 (-0.1%) | 04-19 15:29 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 48.77  |
1-year : | 50.7 |
| Resists | First : | 41.76 |
Second : | 43.4 |
| Pivot price | 41.16 |
|||
| Supports | First : | 39.09 |
Second : | 32.53 |
| MAs | MA(5) : | 39.67 |
MA(20) : | 41.52 |
| MA(100) : | 41.81  |
MA(250) : | 41.09 |
|
| MACD | MACD : | -1 |
Signal : | -0.7 |
| %K %D | K(14,3) : | 3.7 |
D(3) : | 4.7 |
| RSI | RSI(14): 26.8 |
|||
| 52-week | High : | 45.61 | Low : | 34.66 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ XPH ] has closed above bottom band by 5.7%. Bollinger Bands are 62.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 40.11 - 40.31 | 40.31 - 40.5 |
| Low: | 38.99 - 39.24 | 39.24 - 39.48 |
| Close: | 39.12 - 39.51 | 39.51 - 39.9 |
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Tue, 16 Apr 2024
SPY: 10 Reasons To Believe A 10% Decline In The S&P 500 Is Forthcoming - Seeking Alpha
Wed, 03 Apr 2024
Best SPDR ETFs Of April 2024 – Forbes Advisor - Investing - Forbes
Sat, 23 Mar 2024
SPY: Stock Trading Plan AFTER the Fed Announcement - StockNews.com
Thu, 14 Mar 2024
SPY ETF Update, 3/15/2024 - TipRanks.com - TipRanks
Fri, 01 Mar 2024
SPY vs. VOO: Which of Warren Buffett's Two ETFs Is the Better Bet? - Morningstar
Fri, 23 Feb 2024
SPDR S&P 500 ETF tops record $500 billion in assets as Nvidia soars - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|